On March 20, Unitree Robotics officially submitted its IPO application to the Sci-Tech Innovation Board, planning to raise 4.202 billion yuan for projects including R&D of intelligent robots and construction of manufacturing bases. The firm is poised to become the first A-share listed company focused on humanoid robots, igniting capital enthusiasm in China’s high-end manufacturing sector. In recent years, humanoid robots have moved from conceptualization to commercialization, emerging as a core hotspot in the technology track with continuous capital inflow.

As a leading player in China’s humanoid robot industry, Unitree Robotics has delivered impressive operating performance, with a product sell-through rate exceeding 95% in the first three quarters of 2025. Its core technologies cover key areas such as robot motion control and joint actuation, breaking overseas technological monopolies. The funds raised will further strengthen the company’s R&D capabilities and expand production capacity, accelerating the commercial application of humanoid robots in industrial, consumer and special scenarios.

Industry-wide, the global humanoid robot market has entered a high-growth phase, driven by rising demand for robot substitution fueled by industrial automation and population aging. China’s policies have also continued to support high-end manufacturing and innovation in the robot industry, unlocking development opportunities for upstream and downstream industrial chain enterprises. Analysts note that despite its bright prospects, the humanoid robot sector still faces challenges including high technological barriers, slow commercial landing and elevated costs. Going forward, only enterprises with core technologies and mass production capabilities will gain an edge in market competition. Retail investors are advised to stay rational amid the sector’s hype and guard against valuation bubble risks.